ISRGIntuitive Surgical

Health care · Medical Devices · Nasdaq

As part of Intuitive’s mission, we believe that minimally invasive care is life-enhancing care. 10-K, Item 1

Employees: 17,021
Headquarters: Sunnyvale, CA
CEO: David J. Rosa
Next results: around Jan 13, 2027

RevenueFY2016–25 $10.1B+20.5% Highest in 10 years 10-K FY2025 · XBRL Net incomeFY2016–25 $2.9B+23.0% Highest in 10 years 10-K FY2025 · XBRL Free cash flowFY2016–25 $2.5B+91.0% Highest in 10 years 10-K FY2025 · XBRL Operating marginFY2016–25 29.3%+1.1 pts 35.1% in FY2016 10-K FY2025 · XBRL

What changed

10-K filed Feb 3, 2026 against Jan 31, 2025

Area	What changed	Source
Risk factors	17 new paragraphs, nothing like them in the previous 10-K	10-K Item 1A
Accounting checks	11 other checks clear	10-K · XBRL
Insiders	No open-market buys in the last 90 days	Form 4
Filings	3 in the last 30 days	EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

What's new, in their words

10-K filed Feb 3, 2026

Paragraphs in Risk Factors that were not in the 10-K filed 2025-01-31. Quoted as filed.

The UK is in the process of overhauling its medical device regulatory framework following its departure from the European Union (“EU”). The UK regulatory framework will apply in Great Britain only, as Northern Ireland continues to follow the EU Medical Devices Regulation (“MDR”). New post-market surveillance requirements took effect on…
10-K, Item 1A

All 17 new paragraphs →

Accounting checks

latest 10-K

11 of 11 clear 0 worth a look. Checks, not verdicts.

✓
Receivables +24.6% vs revenue +20.5% (+4.1 pts)
✓
Cash from operations $3.0B vs net income $2.9B (FY ending 2025-12-31)
✓
Inventory +23.7% vs revenue +20.5% (+3.2 pts)
✓
Same auditor in both 10-Ks: PricewaterhouseCoopers LLP
✓
No statement of substantial doubt about going concern
✓
No 8-K item 4.02 in the last 2 years
✓
No NT 10-K or NT 10-Q in the last 2 years
✓
The same matters as last year: Determination of Standalone Selling Prices Related to System Sale Arrangements
✓
No sentence in the 10-K concludes that controls were not effective because of a material weakness
✓
No 8-K item 2.06 in the last 2 years
✓
No 8-K item 1.03 in the last 2 years

How each check works, with sources →

In the last 30 days

All filings →

Nov 2, 20268-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
Oct 21, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Oct 20, 20268-K Quarterly results 8-K item 2.02

Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q. RSS feed

Work on ISRG in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/ISRG/export.csv") into a cell.